{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:25:52Z","timestamp":1791339952945,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The differences in prognosis of papillary thyroid carcinoma (PTC) by sex have been investigated in several previous studies, but the results have not been consistent. In addition, the impact of sex on the clinical and pathological characteristics, especially on central lymph node metastasis (CLNM), still remains unknown. To the best of our knowledge, the impact of sex on PTC has not been investigated in the Chinese PTC population. Therefore, our study retrospectively analysed the data of 1339 patients who were diagnosed with PTC and had received radical surgery at Ningbo Medical Center, Lihuili Hospital. In addition to cancer-specific death, structural recurrence and risk stratification, prognosis was also estimated by using three conventional prognostic systems: AMES (age, distant metastasis, extent, size), MACIS (distant metastasis, age, completeness of resection, local invasion, size) and the 8<jats:sup>th<\/jats:sup> version TNM (tumor, lymph node, metastasis) staging system. The clinical and pathological characteristics and above prognostic indexes were compared between male and female PTC patients. The results showed that there were higher rates of non-microcarcinoma PTC (nM-PTC), CLNM, lateral lymph node metastasis (LLNM), advanced disease and bilateral disease, but there was a lower rate of concurrent Hashimoto\u2019s thyroiditis (HT) in male PTC patients than in female PTC patients. Additionally, the rate of intermediate-risk, high-risk or advanced disease was higher in male PTC patients. The above findings indicate that PTC in men is a more aggressive disease and may have a worse prognosis; thus, it should be treated with more caution.<\/jats:p>","DOI":"10.1038\/s41598-020-60199-9","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T11:06:26Z","timestamp":1583406386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma"],"prefix":"10.1038","volume":"10","author":[{"given":"Jinhua","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"60199_CR1","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1378\/chest.130.6.1796","volume":"130","author":"RJ Cerfolio","year":"2006","unstructured":"Cerfolio, R. J. et al. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest. 130, 1796\u20131802 (2006).","journal-title":"Chest."},{"key":"60199_CR2","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1158\/1055-9965.EPI-08-0976","volume":"18","author":"BA Kilfoy","year":"2009","unstructured":"Kilfoy, B. A. et al. Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol. Biomarkers Prev. 18, 1092\u20131100 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"60199_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler, W. E. et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 317, 121\u2013124 (2007).","journal-title":"Science."},{"key":"60199_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2016.06.02","volume":"28","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. National cancer incidence and mortality in China, 2012. Chin. J. Cancer Res. 28, 1\u201311 (2016).","journal-title":"Chin. J. Cancer Res."},{"key":"60199_CR5","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1245\/s10434-017-5788-4","volume":"24","author":"YH Lee","year":"2017","unstructured":"Lee, Y. H. et al. Is Male Gender a Prognostic Factor for Papillary Thyroid Microcarcinoma? Ann. Surg. Oncol. 24, 1958\u20131964 (2017).","journal-title":"Ann. Surg. Oncol."},{"key":"60199_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0","volume":"79","author":"FD Gilliland","year":"1997","unstructured":"Gilliland, F. D. et al. Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973\u20131991. Cancer. 79, 564\u2013573 (1997).","journal-title":"Cancer."},{"key":"60199_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel, R. et al. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10\u201329 (2012).","journal-title":"CA Cancer J. Clin."},{"key":"60199_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1503\/cjs.003816","volume":"59","author":"E Yorke","year":"2016","unstructured":"Yorke, E. et al. Impact of sex on the clinicopathological and prognosis of papillary thyroid cancer. Can. J. Surg. 59, 287\u2013288 (2016).","journal-title":"Can. J. Surg."},{"key":"60199_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer","year":"2009","unstructured":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 19, 1167\u20131214 (2009).","journal-title":"Thyroid."},{"key":"60199_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American Thyroid Association Management Guidelines forAdult Patients with ThyroidNodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 26, 1\u2013133 (2016).","journal-title":"Thyroid."},{"key":"60199_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.yasu.2012.03.002","volume":"46","author":"XM Yu","year":"2012","unstructured":"Yu, X. M., Lloyd, R. & Chen, H. Current treatment of papillary thyroid microcarcinoma. Adv. Surg. 46, 191\u2013203 (2012).","journal-title":"Adv. Surg."},{"key":"60199_CR12","first-page":"947","volume":"104","author":"B Cady","year":"1988","unstructured":"Cady, B. & Ross, R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 104, 947\u2013953 (1988).","journal-title":"Surgery."},{"key":"60199_CR13","first-page":"1050","volume":"114","author":"ID Hay","year":"1993","unstructured":"Hay, I. D. et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during1940 through 1989. Surgery. 114, 1050\u20131058 (1993).","journal-title":"Surgery."},{"key":"60199_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle, R. M., Haugen, B. & Perrier, N. D. Updated American Joint Committee on Cancer\/ Tumor-Node- Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? Thyroid. 27, 751\u2013756 (2017).","journal-title":"Thyroid."},{"key":"60199_CR15","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00268-013-2089-3","volume":"37","author":"DM Hartl","year":"2013","unstructured":"Hartl, D. M. et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J. Surg. 37, 1951\u20131958 (2013).","journal-title":"World J. Surg."},{"key":"60199_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00268-013-2286-0","volume":"38","author":"S Kruijff","year":"2014","unstructured":"Kruijff, S. et al. Patterns of structural recurrence in papillary thyroid cancer. World J. Surg. 38, 653\u2013659 (2014).","journal-title":"World J. Surg."},{"key":"60199_CR17","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1001\/jama.295.18.2179","volume":"295","author":"EL Mazzaferri","year":"2006","unstructured":"Mazzaferri, E. L. Managing small thyroid cancers. JAMA. 295, 2179\u201382 (2006).","journal-title":"JAMA."},{"key":"60199_CR18","first-page":"79","volume":"21","author":"S Rodr\u00edguez-Cuevas","year":"2002","unstructured":"Rodr\u00edguez-Cuevas, S., Labastida-Almendaro, S., Cort\u00e9s-Arroyo, H., L\u00f3pez-Garza, J. & Barroso-Bravo, S. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer: comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. J. Exp. Clin. Cancer Res. 21, 79\u201386 (2002).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"60199_CR19","first-page":"4283","volume":"23","author":"PE Voutilainen","year":"2003","unstructured":"Voutilainen, P. E. et al. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma. Anticancer. Res. 23, 4283\u20134288 (2003).","journal-title":"Anticancer. Res."},{"key":"60199_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/bjs.9056","volume":"100","author":"J Kirkby-Bott","year":"2013","unstructured":"Kirkby-Bott, J. Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br. J. Surg. 100, 503\u2013504 (2013).","journal-title":"Br. J. Surg."},{"key":"60199_CR21","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1210\/jc.2011-1546","volume":"97","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J. Clin. Endocrinol. Metab. 97, 1250\u20131257 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60199_CR22","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1210\/jc.2012-3728","volume":"98","author":"P Malandrino","year":"2013","unstructured":"Malandrino, P. et al. Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J. Clin. Endocrinol. Metab. 98, 1427\u20131434 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60199_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1245\/s10434-011-2098-0","volume":"19","author":"JD Prescott","year":"2012","unstructured":"Prescott, J. D. & Parangi, S. Bilaterality in Papillary Thyroid Carcinoma: Does It Influence Prognosis? Ann. Surg. Oncol. 19, 1\u20132 (2012).","journal-title":"Ann. Surg. Oncol."},{"key":"60199_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1503\/cjs.014615","volume":"59","author":"SE Moore","year":"2016","unstructured":"Moore, S. E., Kasaian, K., Jones, S., Melck, A. & Wiseman, S. M. Clinical importance of bilateral disease in patients with papillary thyroid cancer. Can. J. Surg. 59, 213\u2013215 (2016).","journal-title":"Can. J. Surg."},{"key":"60199_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3342\/ceo.2015.8.2.174","volume":"8","author":"YK So","year":"2015","unstructured":"So, Y. K., Kim, M. W. & Son, Y. I. Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma. Clin. Exp. Otorhinolaryngol. 8, 174\u2013178 (2015).","journal-title":"Clin. Exp. Otorhinolaryngol."},{"key":"60199_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4174\/jkss.2013.85.1.20","volume":"85","author":"YS Kim","year":"2013","unstructured":"Kim, Y. S., Choi, H. J. & Kim, E. S. Papillary thyroid carcinoma with thyroiditis: lymph node metastasis, complications. J. Korean Surg. Soc. 85, 20\u201324 (2013).","journal-title":"J. Korean Surg. Soc."},{"key":"60199_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/1477-7819-12-277","volume":"12","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. The effect of chronic lymphocyticthyroiditis on patients with thyroid cancer. World J. Surg. Oncol. 12, 277 (2014).","journal-title":"World J. Surg. Oncol."},{"key":"60199_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","volume":"27","author":"JS Jeong","year":"2012","unstructured":"Jeong, J. S. et al. Coexistence of Chronic Lymphocytic Thyroiditis with Papillary Thyroid Carcinoma: Clinical Manifestation and Prognostic Outcome. J. Korean Med. Sci. 27, 883\u2013889 (2012).","journal-title":"J. Korean Med. Sci."},{"key":"60199_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","volume":"84","author":"KC Loh","year":"1999","unstructured":"Loh, K. C., Greenspan, F. S., Dong, F., Miller, T. R. & Yeo, P. P. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 84, 458\u2013463 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60199_CR30","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1067\/msy.2099.101431","volume":"126","author":"B Singh","year":"1999","unstructured":"Singh, B. et al. Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 126, 1070\u20131076 (1999).","journal-title":"Surgery."},{"key":"60199_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.1998.8.197","volume":"8","author":"K Kashima","year":"1998","unstructured":"Kashima, K. et al. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 8, 197\u2013202 (1998).","journal-title":"Thyroid."},{"key":"60199_CR32","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1210\/jc.2013-1309","volume":"98","author":"S Dvorkin","year":"2013","unstructured":"Dvorkin, S. et al. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J. Clin. Endocrinol. Metab. 98, 2409\u20132414 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60199_CR33","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/thy.2013.0698","volume":"24","author":"C Durante","year":"2014","unstructured":"Durante, C. et al. Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies. Thyroid. 24, 1139\u20131145 (2014).","journal-title":"Thyroid."},{"key":"60199_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1055\/a-0648-4593","volume":"50","author":"Y Nagayama","year":"2018","unstructured":"Nagayama, Y. Thyroid Autoimmunity and Thyroid Cancer - The Pathogenic Connection: A 2018 Update. Horm. Metab. Res. 50, 922\u2013931 (2018).","journal-title":"Horm. Metab. Res."},{"key":"60199_CR35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12020-012-9853-2","volume":"44","author":"H Yu","year":"2013","unstructured":"Yu, H. et al. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter. Endocrine. 44, 172\u2013181 (2013).","journal-title":"Endocrine."},{"key":"60199_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5603\/FHC.2014.0002","volume":"52","author":"A Lewinski","year":"2014","unstructured":"Lewinski, A., Sliwka, P. W. & Stasiolek, M. Dendritic cells in autoimmune disorders and cancer of the thyroid. Folia Histochem. Cytobiol. 52, 18\u201328 (2014).","journal-title":"Folia Histochem. Cytobiol."},{"key":"60199_CR37","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-13-0436","volume":"21","author":"S Imam","year":"2014","unstructured":"Imam, S., Paparodis, R., Sharma, D. & Jaume, J. C. Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. Endocr. Relat. Cancer. 21, 505\u2013516 (2014).","journal-title":"Endocr. Relat. Cancer."},{"key":"60199_CR38","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/carcin\/bgu060","volume":"35","author":"W Fang","year":"2014","unstructured":"Fang, W. et al. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Carcinogenesis. 35, 1780\u20131787 (2014).","journal-title":"Carcinogenesis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60199-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:30:49Z","timestamp":1670311849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60199-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60199"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60199-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4141"}}